Skip to content

Clinical trials

Completed Observational Essential Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Essential Hypertension Phase: Observational Status: Completed Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20061
20075
20081
20102
20112
20121
20132
20141
20154
20173
20186
20192
20211
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Boryung Pharmaceutical Co., Ltd3
Bayer2
Celltrion Pharm, Inc.2
Novartis Pharmaceuticals2
A.Menarini Asia-Pacific Holdings Pte Ltd1
Abbott1
Assistance Publique - Hôpitaux de Paris1
Centre Hospitalier Universitaire Vaudois1
DongGuk University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Essential Hypertension39
Hypertension15
Hyperaldosteronism3
Hypertrophy, Left Ventricular2
Adrenocortical Adenoma1
Atrial Fibrillation1
Cardiovascular Diseases1
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Diabetic Nephropathies1

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.